The largest database of trusted experimental protocols

5 protocols using agilent array scanner

1

Microarray Analysis of Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microarray analysis was performed as previously described (Pai et al., 2014 (link); Rallis et al., 2013 (link)). Experiments were conducted in duplicate with a dye swap. RNAs from two independent biological replicates have been utilized for cDNA production. Fig. 6C shows average expression ratios from the two repeats. Original data have been deposited in ArrayExpress under accession number E-MTAB-6795. In brief, Alexa Fluor 555- or 647-labelled cDNA was produced from the RNA, using a Superscript direct cDNA labelling system (Invitrogen) and Alexa Fluor 555 and 647 dUTP mix. cDNAs were then purified using an Invitrogen PureLink PCR Purification system and hybridized to the array using a Gene Expression Hybridization kit (Agilent). The arrays are Agilent custom-designed containing 60-mer oligonucleotides synthesized in situ containing 15,000 probes. Following hybridization for at least 17 h, the arrays were washed using a Gene Expression Wash Buffer kit (Agilent) and scanned in an Agilent Array Scanner. Signals were extracted using GenePix software.
+ Open protocol
+ Expand
2

Array-CGH Analysis of Genomic Copy Number

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was isolated from SUM44 and LCCTam cells, the latter cultured in the absence of 4HT for 14 days, using the illustra triplePrep kit (GE Healthcare, Buckinghamshire, UK) according to manufacturer’s instructions. DNA copy number analysis was performed using an oligonucleotide array-CGH platform (SurePrint G3 Human CGH Microarray 8×60K; Agilent Technologies Inc., Santa Clara, CA), as published previously (Torresan, et al. 2014 (link)). DNA isolated from peripheral blood from multiple normal individuals was used as reference DNA. Briefly, equal amounts of cell line and reference DNA were directly labeled with Cy3 and Cy5, respectively, using the SureTag Labeling Kit (Agilent Technologies) and hybridized in the presence of human Cot1-DNA (Life Technologies) to the array for 40 hours. The array was scanned using an Agilent array scanner and data was extracted using Feature Extraction (FE) software v10.10. For data analysis we used two different global analysis methods: Aberration Detection Module-2 (ADM-2, Agilent Technologies) and Circular Binary Segmentation (CBS).
+ Open protocol
+ Expand
3

Comprehensive Genomic Profiling Using CGH

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was isolated and labelled using Agilent-recommended protocol. CGH was performed on an Agilent Microarray platform with 105k probes (Agilent Inc., Santa Clara, CA). Array image was acquired with an Agilent Array Scanner. Microarray data was analyzed using the Cytogenomics software package from Agilent Inc. Interpretation of detected CNVs was conducted according to the ACMG standards and guidelines revision 2013 [13 (link)], and technical standards recommendation by ACMG and ClinGen [14 (link)]. Information for clinical significance on reported cases was extracted from Databases of Genomic Variants (ClinVar) at www.ncbi.nim.nih.gov/clinvar, and DECIPHER at www.decipher.sanger.ac.uk. Association analysis of gene function and clinical features is based on the information from Online Mendelian Inheritance in Man (OMIM at www.omim.org).
+ Open protocol
+ Expand
4

Comprehensive Genomic Profiling Using CGH

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was isolated and labelled using Agilent-recommended protocol. CGH was performed on an Agilent Microarray platform with 105k probes (Agilent Inc., Santa Clara, CA). Array image was acquired with an Agilent Array Scanner. Microarray data was analyzed using the Cytogenomics software package from Agilent Inc. Interpretation of detected CNVs was conducted according to the ACMG standards and guidelines revision 2013 [13 (link)], and technical standards recommendation by ACMG and ClinGen [14 (link)]. Information for clinical significance on reported cases was extracted from Databases of Genomic Variants (ClinVar) at www.ncbi.nim.nih.gov/clinvar, and DECIPHER at www.decipher.sanger.ac.uk. Association analysis of gene function and clinical features is based on the information from Online Mendelian Inheritance in Man (OMIM at www.omim.org).
+ Open protocol
+ Expand
5

MicroRNA Microarray Analysis Pipeline

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted using TRIzol (Invitrogen Life Technologies) according to the manufacturer’s instruction. RNA quality was assessed by using the Agilent 2100 bioanalyzer (Agilent Technologies), and only samples with RNA integrity number >8 were used. MicroRNA microarray Assay was done using miRbase version 21.0 by LC Sciences (LC Sciences, Houston, TX). Array experiments were conducted according to the manufacturer’s instructions. Briefly, the miRNAs were labeled with Agilent miRNA labeling reagent (Agilent Technologies). Then, dephosphorylated RNA was linked with pCp-y3 and the labeled RNA was purified and hybridized to the miRNA microarray. Images were scanned with the Agilent array scanner (Agilent Technologies) using a grid file and analyzed with Agilent feature extraction software version 10.10.
GeneSpring software V12 (Agilent Technologies) was used for summarization, normalization, and quality control of miRNA microarray data. The miRNA array data were calculated by first subtracting the background value and then normalizing the signals by locally weighted regression. The express levels of miRNAs were designated as statistically significant when the 2-tailed P value was ≤0.05. And signals <500 were interpreted as false-positive result. The statistically significant messenger RNAs were selected based on the fold change and adjusted P value ≤0.05.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!